Conference
Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab
Authors
Mukherjee M; Aleman F; Kjarsgaard M; Radford K; LaVigne N; Salter B; Sehmi R; Nair P
Publisher
European Respiratory Society (ERS)
Publication Date
September 1, 2017
DOI
10.1183/1393003.congress-2017.pa4768
Name of conference
Monitoring Airway Disease